StockData
Adagene Inc. logo

Adagene Inc. (ADAG) stock

ADAGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 5/30
$1.48−0.12 (-7.50%)

Close on Nov 17, 2026Market cap $87.66MP/E –Yield –

Adagene total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Adagene's total debt was $5.73M at Jun 30, 2026. For fiscal 2025 it was $6.12M, down 66.4% from the year before. The highest annual figure on record is $27.77M in fiscal 2022.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.12M-66.4%
FY2024Dec 31, 2024$18.21M-17.0%
FY2023Dec 31, 2023$21.94M-21.0%
FY2022Dec 31, 2022$27.77M+270.7%
FY2021Dec 31, 2021$7.49M-6.2%
FY2020Dec 31, 2020$7.98M+212.4%
FY2019Dec 31, 2019$2.56M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$5.73M-72.1%
Q4 FY2025Dec 31, 2025$6.12M-72.1%
Q2 FY2025Jun 30, 2025$6.64M-76.1%
Q4 FY2024Dec 31, 2024$18.21M+143.1%
Q2 FY2024Jun 30, 2024$20.54M+157.3%
Q4 FY2023Dec 31, 2023$21.94M+758.6%
Q4 FY2022Dec 31, 2022$27.77M–
Q4 FY2021Dec 31, 2021$7.49M–
Q4 FY2020Dec 31, 2020$7.98M–
Q4 FY2019Dec 31, 2019$2.56M–

More Adagene figures

See a number that looks wrong?